BR112018010163A2 - formulação, e, método para tratamento de infecção por hiv - Google Patents
formulação, e, método para tratamento de infecção por hivInfo
- Publication number
- BR112018010163A2 BR112018010163A2 BR112018010163A BR112018010163A BR112018010163A2 BR 112018010163 A2 BR112018010163 A2 BR 112018010163A2 BR 112018010163 A BR112018010163 A BR 112018010163A BR 112018010163 A BR112018010163 A BR 112018010163A BR 112018010163 A2 BR112018010163 A2 BR 112018010163A2
- Authority
- BR
- Brazil
- Prior art keywords
- formulation
- hiv infection
- treating hiv
- hiv
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Abstract
coformulações do composto inibidor de maturação do hiv com um ou dois outros compostos do hiv, e métodos para tratamento, são apresentados.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562257871P | 2015-11-20 | 2015-11-20 | |
US201662376516P | 2016-08-18 | 2016-08-18 | |
PCT/IB2016/056956 WO2017085677A2 (en) | 2015-11-20 | 2016-11-18 | Hiv maturation inhibitor formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112018010163A2 true BR112018010163A2 (pt) | 2018-11-21 |
Family
ID=57406290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018010163A BR112018010163A2 (pt) | 2015-11-20 | 2016-11-18 | formulação, e, método para tratamento de infecção por hiv |
Country Status (12)
Country | Link |
---|---|
US (1) | US20200268772A1 (pt) |
EP (1) | EP3377177A2 (pt) |
JP (1) | JP2018534322A (pt) |
KR (1) | KR20180081598A (pt) |
CN (1) | CN108348778A (pt) |
AU (1) | AU2016356335A1 (pt) |
BR (1) | BR112018010163A2 (pt) |
CA (1) | CA3004856A1 (pt) |
IL (1) | IL259215A (pt) |
RU (1) | RU2018116772A (pt) |
TW (1) | TW201726133A (pt) |
WO (1) | WO2017085677A2 (pt) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110079783A (ko) | 2003-02-19 | 2011-07-07 | 예일 유니버시티 | 항-바이러스 뉴클레오시드 유사체 및 바이러스 감염, 특히 에이치아이브이 감염의 치료방법 |
WO2006129134A1 (en) * | 2005-06-01 | 2006-12-07 | Bioalliance Pharma | Synergic combinations comprising a styrylquinoline compound and other hiv infection therapeutic agents |
US20080039428A1 (en) * | 2006-06-29 | 2008-02-14 | Panacos Pharmaceuticals, Inc. | Antiretroviral combination therapy |
AU2014202405B2 (en) * | 2010-01-27 | 2016-02-25 | Viiv Healthcare Company | Antiviral therapy |
BR112013019419A2 (pt) * | 2011-01-31 | 2019-12-03 | Bristol-Myers Squibb Company | triterpenoides modificados por c-17 e c-3 com atividade inibitória de maturação de hiv |
CN103288832A (zh) * | 2012-03-01 | 2013-09-11 | 世方药业(杭州)有限公司 | 具有抗病毒特性的吡咯并哒嗪类化合物 |
IN2013MU01749A (pt) * | 2013-05-15 | 2015-06-26 | Cipla Ltd | |
MA39374A1 (fr) * | 2014-04-11 | 2018-06-29 | Viiv Healthcare Uk No 4 Ltd | Triterpénoïdes présentant une activité d'inhibition de la maturation du vih, substitués en 3ème position par un cycle non aromatique portant un substituant halogénoalkyle |
-
2016
- 2016-11-18 CA CA3004856A patent/CA3004856A1/en not_active Abandoned
- 2016-11-18 JP JP2018526093A patent/JP2018534322A/ja active Pending
- 2016-11-18 CN CN201680065725.6A patent/CN108348778A/zh active Pending
- 2016-11-18 EP EP16801849.7A patent/EP3377177A2/en not_active Withdrawn
- 2016-11-18 US US15/776,461 patent/US20200268772A1/en not_active Abandoned
- 2016-11-18 WO PCT/IB2016/056956 patent/WO2017085677A2/en active Application Filing
- 2016-11-18 AU AU2016356335A patent/AU2016356335A1/en not_active Abandoned
- 2016-11-18 BR BR112018010163A patent/BR112018010163A2/pt not_active Application Discontinuation
- 2016-11-18 RU RU2018116772A patent/RU2018116772A/ru not_active Application Discontinuation
- 2016-11-18 TW TW105137956A patent/TW201726133A/zh unknown
- 2016-11-18 KR KR1020187016922A patent/KR20180081598A/ko unknown
-
2018
- 2018-05-08 IL IL259215A patent/IL259215A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2017085677A2 (en) | 2017-05-26 |
IL259215A (en) | 2018-07-31 |
AU2016356335A1 (en) | 2018-05-31 |
RU2018116772A (ru) | 2019-12-20 |
TW201726133A (zh) | 2017-08-01 |
CA3004856A1 (en) | 2017-05-26 |
EP3377177A2 (en) | 2018-09-26 |
KR20180081598A (ko) | 2018-07-16 |
JP2018534322A (ja) | 2018-11-22 |
WO2017085677A3 (en) | 2017-07-20 |
CN108348778A (zh) | 2018-07-31 |
US20200268772A1 (en) | 2020-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201891200A1 (ru) | Композиции, содержащие бактериальные штаммы | |
MX2023003461A (es) | Tratamiento de infeccion por clostridium difficile. | |
BR112018008326A2 (pt) | composições e métodos para o tratamento de câncer | |
EA201890201A1 (ru) | Антибактериальные соединения | |
EA201891970A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA201990043A1 (ru) | Антибактериальные соединения | |
BR112017002332A2 (pt) | terapia de combinação para o tratamento de um paramixovírus | |
CL2018000596A1 (es) | Nuevos compuestos bicíclicos como inhibidores de la atx | |
EA202091602A1 (ru) | Системы и способы для обработки биологических жидкостей | |
EA201691726A1 (ru) | Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b | |
PH12017500393A1 (en) | Pyrrolopyrimidines for use in influenza virus infection | |
WO2017083431A3 (en) | Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections | |
EA201990296A1 (ru) | Антитела против siglec-7 для лечения рака | |
EA201792006A1 (ru) | Антимикробные соединения и способы их получения и их применение | |
BR112018011709A2 (pt) | inibidores bicíclicos de pad4 | |
MX2017007829A (es) | Composicion antimicrobiana. | |
EA201692358A1 (ru) | Производные изоиндолина для применения в лечении вирусной инфекции | |
BR112017004153A2 (pt) | métodos para tratamento de infecções por protozoários | |
MX2018009325A (es) | Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn). | |
BR112018070497A2 (pt) | métodos e formulações farmacêuticas para tratamento de condições oculares | |
MX2017012073A (es) | Compuestos de minociclina para biodefensas. | |
MD3630136T2 (ro) | Compoziții care cuprind tulpini bacteriene | |
BR112018005331A2 (pt) | inibidores de pcna | |
MX2018005987A (es) | Compuestos heterociclicos para el tratamiento de enfermedades. | |
BR112017020374A2 (pt) | compostos bicíclicos fundidos para o tratamento de doença |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |